albuterol has been researched along with Coronary Artery Disease in 7 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coronary vasodilator function and atherosclerotic plaque progression have both been shown to be associated with adverse cardiovascular events." | 2.87 | Evaluation of human coronary vasodilator function predicts future coronary atheroma progression. ( Baillie, TJ; Beltrame, JF; Delacroix, S; Honda, S; Howell, S; Kim, S; Montarello, N; Nicholls, SJ; Psaltis, PJ; Shishikura, D; Sidharta, SL; Worthley, MI; Worthley, SG, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sidharta, SL | 1 |
| Baillie, TJ | 1 |
| Howell, S | 1 |
| Nicholls, SJ | 4 |
| Montarello, N | 1 |
| Honda, S | 1 |
| Shishikura, D | 1 |
| Delacroix, S | 1 |
| Kim, S | 1 |
| Beltrame, JF | 4 |
| Psaltis, PJ | 1 |
| Worthley, SG | 4 |
| Worthley, MI | 4 |
| Puri, R | 3 |
| Leong, DP | 1 |
| Liew, GY | 3 |
| Nelson, AJ | 3 |
| Carbone, A | 3 |
| Copus, B | 3 |
| Wong, DT | 1 |
| Brennan, DM | 2 |
| Andrews, J | 2 |
| King, KL | 1 |
| Kapadia, SR | 2 |
| Tuzcu, EM | 2 |
| Hayward, CS | 1 |
| Kraidly, M | 1 |
| Webb, CM | 1 |
| Collins, P | 1 |
| Barbato, E | 1 |
| Piscione, F | 1 |
| Bartunek, J | 1 |
| Galasso, G | 1 |
| Cirillo, P | 1 |
| De Luca, G | 1 |
| Iaccarino, G | 1 |
| De Bruyne, B | 1 |
| Chiariello, M | 1 |
| Wijns, W | 1 |
| Wykretowicz, A | 1 |
| Guzik, P | 1 |
| Bartkowiak, G | 1 |
| Krauze, T | 1 |
| Kasinowski, R | 1 |
| Dziarmaga, M | 1 |
| Wesseling, KH | 1 |
| Wysocki, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of a Peripheral Endothelial Dysfunction in COPD (Chronic Obstructive Pulmonary Disease)[NCT02593357] | 137 participants (Actual) | Interventional | 2012-12-17 | Completed | |||
| Peripheral Endothelial Function in Asthmatic Patients[NCT02593344] | 113 participants (Actual) | Interventional | 2012-12-13 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for albuterol and Coronary Artery Disease
| Article | Year |
|---|---|
Evaluation of human coronary vasodilator function predicts future coronary atheroma progression.
Topics: Aged; Albuterol; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progressio | 2018 |
Assessment of endothelial function using peripheral waveform analysis: a clinical application.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Body Mass Index; Coronary Artery Disease | 2002 |
Assessment of endothelial function using peripheral waveform analysis: a clinical application.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Body Mass Index; Coronary Artery Disease | 2002 |
Assessment of endothelial function using peripheral waveform analysis: a clinical application.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Body Mass Index; Coronary Artery Disease | 2002 |
Assessment of endothelial function using peripheral waveform analysis: a clinical application.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Body Mass Index; Coronary Artery Disease | 2002 |
5 other studies available for albuterol and Coronary Artery Disease
| Article | Year |
|---|---|
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Coronary Angiography; Coronary Artery Disease; Coron | 2015 |
Left main coronary arterial endothelial function and heterogenous segmental epicardial vasomotor reactivity in vivo: novel insights with intravascular ultrasonography.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Biomarkers; Coronary Angiography; Coronary Artery Di | 2014 |
Coronary atheroma composition and its association with segmental endothelial dysfunction in non-ST segment elevation myocardial infarction: novel insights with radiofrequency (iMAP) intravascular ultrasonography.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cardiac Catheters; Coronary Artery Disease; Co | 2015 |
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
Topics: Acetylcholine; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Albutero | 2005 |
Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels.
Topics: Adult; Aged; Aging; Albuterol; Angioplasty, Balloon, Coronary; Baroreflex; Blood Glucose; Coronary A | 2005 |